Related Experiment Videos
The role of clonal selection and somatic mutation in autoimmunity
Nature
|August 2, 1987
Summary
Autoimmune diseases may not stem from general immune activation. Rheumatoid factor (RF) autoantibodies in MRL/lpr mice show antigen-driven selection, suggesting specific B cell responses are involved.
Area of Science:
- Immunology
- Autoimmunity
- Molecular Biology
Background:
- Polyclonal activation is a proposed mechanism for autoantibody production in autoimmune diseases.
- This model suggests a multiclonal, unmutated, or randomly mutated autoantibody population.
- It does not account for specific antigen selection of B cells.
Purpose of the Study:
- To investigate the origin and characteristics of immunoglobulin G (IgG) autoantibodies targeting self-IgG (rheumatoid factor, RF) in MRL/lpr mice.
- To determine if autoantibody production aligns with polyclonal activation or antigen-driven selection models.
Main Methods:
- Analysis of genetic features and clonal composition of spontaneously derived RF autoantibodies from MRL/lpr mice.
- Comparison of autoantibody characteristics with predictions from polyclonal activation models and experimental polyclonal activation outcomes.
Main Results:
- MRL/lpr RF autoantibodies are oligoclonal or monoclonal, contradicting the polyclonal activation model.
- These autoantibodies possess numerous somatic mutations, indicative of selection.
- Mutation patterns suggest immunoglobulin-receptor-dependent selection, similar to responses against exogenous antigens.
Conclusions:
- The findings challenge the polyclonal activation model for autoantibody generation in MRL/lpr mice.
- Antigen stimulation and selection processes, akin to secondary immune responses, appear crucial for generating MRL/lpr RF autoantibodies.
- This suggests a role for specific antigen selection in autoimmune B cell responses.